Dr. Finger teaches that radiation retinopathy starts at the time of ophthalmic radiation therapy, its severity is dose-dependent and that it can be suppressed. Dr. Finger's research has described the threshold radiation doses that were associated with the development of radiation maculopathy, the timing of symptoms and how to prevent or delay secondary vision loss. Dr. Finger teaches how he uses anti-VEGF medications to suppress radiation retinopathy. That said, you can see his visual acuity results by visiting his website [ Ссылка ] as he publishes his outcomes after plaque therapy for choroidal melanoma. Look to see what the most common visual acuity is for his eye plaque patients on his doctor reported outcome pages.
